Drug Discovery Solutions
-
Expediting Drug Discovery From Concept To Commercialization
8/13/2024
Explore a suite of services designed to accelerate drug discovery and development, from custom reagent production and high-throughput screening to advanced in vitro pharmacology and DMPK assays.
-
CRISPR/Cas9 And Cas9 Variants
9/30/2025
A quick overview of this industry-changing technology as well as the newer Cas9 variants that expand its use.
-
Early Phase Bioassays And Analytics
6/26/2024
The development of phase-appropriate, tailored bioassays is crucial. By identifying promising candidates, bioassays streamline the development process, enabling informed decision-making.
-
PUREplatform PUREcoli, A Pure Microbial Strain For Protein Production
3/17/2023
PUREplatform offers a platform, a premium strain, and cutting-edge screening, which together yield optimal protein expression that is uniquely tailored to each project.
-
Meet MaruXTM: Setting The Standard For End-To-End Continuous Biomanufacturing
5/13/2026
Continuous biomanufacturing boosts speed, flexibility, and control. Modular automation, intensified processing, and streamlined workflows drive productivity and consistent quality.
-
CHEF1™ Expression Technology
2/17/2022
The platform accelerates development of cell lines for cGMP production by using robust procedures and reliable raw materials, including chemically defined media, adapted Chinese hamster ovary (CHO) cells, and proprietary expression plasmids, to rapidly produce high levels of recombinant protein.
-
Analytical Labs Particle Analysis
Particulate in a drug product represents a huge risk not only to patient safety – but also to a drug company’s reputation and bottom line. As concern about particulate rises, partnering with a particle analysis team enables customers to gain an intimate understanding of particle sources related to packaging and delivery systems.
-
Leveraging Proprietary CDO Platforms
Explore how a suite of proprietary CDO platforms for BsAbs, transient expression, developability assessment, and more can help optimize every stage of development and accelerate your project timeline.
-
TARGATT™ HEK293 Kits
9/30/2025
Accelerate cell line development for library creation and protein expression with efficient TARGATT™ large knock-in technology.
-
SUREmAb — Monoclonal Antibody Development, The Way It's Meant To Be
8/4/2023
Leverage robust development strategies and enable an optimized process for mAb development and manufacturing, efficiency and speed with exceptional quality, and high titers with lower-cost workflows for maximum ROI.